Showing 1 - 20 results of 264 for search '"year"', query time: 0.10s Refine Results
  1. 1
  2. 2
  3. 3

    Risk Predictors of 3-Month and 1-Year Outcomes in Heart Failure Patients with Prior Ischemic Stroke by Ding Li, Yu Wang, Feng Ze, Xu Zhou, Xue-Bin Li

    Published 2022-10-01
    “…The other factors, such as being without ACEI/ARB and a high heart rate, only increase risks before 3 months or 1 year, not both.…”
    Get full text
    Article
  4. 4
  5. 5
  6. 6

    Hemivertebra resection after age three produces the similar results but with less complications compared to earlier surgery: a minimum of 5-year follow-up by Yu Wang, Xu Sun, Wenhan Li, Benlong Shi, Zhen Liu, Bin Wang, Yong Qiu, Zezhang Zhu

    Published 2023-09-01
    “…Early intervention before 3 years of age seems being able to get better correction with less fusion segments. …”
    Get full text
    Article
  7. 7

    A nomogram based on cuproptosis-related genes predicts 7-year relapse-free survival in patients with estrogen receptor-positive early breast cancer by Yu Fan, Chuanxu Luo, Yu Wang, Zhu Wang, Chengshi Wang, Xiaorong Zhong, Kejia Hu, Yanping Wang, Donghao Lu, Donghao Lu, Hong Zheng

    Published 2023-05-01
    “…The area under the receiver operating characteristic (ROC) curve (AUC) of the nomogram was significantly higher than the AUC of the CRG score at 7 years.ConclusionsThe CRG score, combined with other clinical features, could afford a practical long-term outcome predictor in patients with ER+ EBC.…”
    Get full text
    Article
  8. 8

    Association between non-HDLC and 1-year prognosis in patients with spontaneous intracerebral haemorrhage: a prospective cohort study from 13 hospitals in Beijing by Yu Wang, Xingquan Zhao, Anxin Wang, Jianwei Wu, Wenjuan Wang, Ruixuan Jiang

    Published 2022-11-01
    “…Moreover, sensitivity analysis was performed in ICH patients without statin use after admission.Results There were 33.5% (223/666) ICH patients identified with unfavourable functional outcomes at 1-year follow-up. In the univariate analysis, patients who achieved non-HDLC levels above 4.2 mmol/L had a 49% decreased risk of 1-year poor prognosis (OR 0.51, 95% CI 0.33 to 0.81). …”
    Get full text
    Article
  9. 9
  10. 10

    Cervical and endometrial cancers of intestinal origin diagnosed 18 years after vaginal replacement with a sigmoid colon segment: a case report and review of the literature by Xiao-fei Sun, Xin-xin Miao, Bao-xuan Li, Yu Wang

    Published 2022-07-01
    “…Malignant tumors of neovaginas derived from sigmoid colons are rare.Case presentationWe report a 33-year-old woman who underwent sigmoid colpoplasty for vaginal agenesis and presented 18 years later with vaginal bleeding. …”
    Get full text
    Article
  11. 11
  12. 12

    Haploidentical hematopoietic stem cell transplantation may improve long-term survival for children with high-risk T-cell acute lymphoblastic leukemia in first complete remission by Yongzhan Zhang, Lu Bai, Yifei Cheng, Aidong Lu, Yu Wang, Jun Wu, Xiaohui Zhang, Yingxi Zuo, Lanping Xu, Yueping Jia, Xiaojun Huang, Leping Zhang, Peng Lyu

    Published 2022-04-01
    “…In HR patients, allo-HSCT improved the 5-year EFS and CIR compared to that of chemotherapy (5-year EFS: 80.1% vs. 54.1%, P = 0.041; 5-year CIR: 11.6% vs. 45.2%, P = 0.006). …”
    Get full text
    Article
  13. 13

    Effects of isolated central nervous system involvement evaluated by multiparameter flow cytometry prior to allografting on outcomes of patients with acute lymphoblastic leukemia by Ling Ma, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han, Yu-Qian Sun, Chen-Hua Yan, Meng Lv, Fei-Fei Tang, Xiao-Dong Mo, Zhi-Dong Wang, Qian Jiang, Jin Lu, Hao Jiang, Yan-Rong Liu, Kai-Yan Liu, Ying-Jun Chang, Xiao-Jun Huang

    Published 2023-05-01
    “…Compared with the negative CNS group (n=1332), the 5-year CIR of the pre-HSCT CNS involvement group (n=74) was higher (46.3% vs. 23.4%, P<0.001], and the 5-year LFS was inferior (39.1% vs. 60.8%, P<0.001). …”
    Get full text
    Article
  14. 14

    Identification of NO<sub>2</sub> and SO<sub>2</sub> Pollution Hotspots and Sources in Jiangsu Province of China by Yu Wang, Md. Arfan Ali, Muhammad Bilal, Zhongfeng Qiu, Alaa Mhawish, Mansour Almazroui, Shamsuddin Shahid, M. Nazrul Islam, Yuanzhi Zhang, Md. Nazmul Haque

    Published 2021-09-01
    “…Furthermore, the implementation of China’s strict air pollution control policies caused a larger decrease in SO<sub>2</sub> (per year) during the 12th FYP period (−0.002~−0.075 DU/year) than in the 11th FYP period (−0.014~−0.071 DU/year), the APPC-AC period (−0.007~−0.043 DU/year), and 2005–2020 (−0.015~−0.032 DU/year). …”
    Get full text
    Article
  15. 15

    Serological surveillance of GI norovirus reveals persistence of blockade antibody in a Jidong community-based prospective cohort, 2014–2018 by Jing-Rong Yu, Jing-Rong Yu, Dong-Jie Xie, Dong-Jie Xie, Jia-Heng Li, Mark Momoh Koroma, Lu Wang, Yu Wang, Duo-Na Jing, Jia-Yi Xu, Jun-Xuan Yu, Hui-Sha Du, Fei-Yuan Zhou, Zhi-Yan Liang, Xu-Fu Zhang, Xu-Fu Zhang, Ying-Chun Dai

    Published 2023-12-01
    “…The overall decay rate of anti-GI.2 antibody was -5.9%/year (95% CI: -7.1% to -4.8%/year), which was significantly faster than that of GI.3 [-3.6%/year (95% CI: -4.6% to -2.6%/year)] and GI.9 strains [-4.0%/year (95% CI: -4.7% to -3.3%/year)]. …”
    Get full text
    Article
  16. 16

    Analysis of the differences in physicochemical properties, volatile compounds, and microbial community structure of pit mud in different time spaces by Baolin Han, Hucheng Gong, Xiaohu Ren, Shulin Tian, Yu Wang, Shufan Zhang, Jiaxu Zhang, Jing Luo

    Published 2024-02-01
    “…The physicochemical properties and ester content of the 40-year PM were higher than those of the 10-year PM, but the spatial distribution of the two years PM samples exhibited no consistency, except in terms of pH, available phosphorus content, and ester content. …”
    Get full text
    Article
  17. 17

    Response to induction chemotherapy predicts survival outcomes in oropharyngeal cancer by Qixian Zhang, Tingting Xu, Chunying Shen, Wei Qian, Hongmei Ying, Xiayun He, Yu Wang, Qinghai Ji, Chaosu Hu, Xin Zhou, Xueguan Lu

    Published 2023-04-01
    “…Compared with IC‐r subgroup, IC‐s was associated with better clinical outcomes either in the entire cohort (3y‐PFS 91.7%vs.43.7%, P < 0.001; 3y‐OS 98.3% vs. 67.4%, P = 0.002), the HPV‐positive subgroup (3‐year PFS 94.7% vs. 47.9%, P < 0.001; 3‐year OS 100% vs. 73.5%, P = 0.055) or the HPV‐negative subgroup (3‐year PFS 88.2% vs. 40.9%, P = 0.001; 3‐year OS 96.4% vs. 63.1%, P = 0.026). …”
    Get full text
    Article
  18. 18
  19. 19

    Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors by Xiaopeng Guo, Xiaopeng Guo, Yixin Shi, Yixin Shi, Delin Liu, Delin Liu, Yilin Li, Yilin Li, Wenlin Chen, Yaning Wang, Yuekun Wang, Hao Xing, Yu Xia, Yu Xia, Junlin Li, Junlin Li, Jiaming Wu, Jiaming Wu, Tingyu Liang, Hai Wang, Qianshu Liu, Qianshu Liu, Shanmu Jin, Shanmu Jin, Tian Qu, Tian Qu, Siying Guo, Siying Guo, Huanzhang Li, Huanzhang Li, Tianrui Yang, Tianrui Yang, Kun Zhang, Kun Zhang, Yu Wang, Yu Wang, Wenbin Ma, Wenbin Ma

    Published 2023-03-01
    “…This study aimed to depict the clinical, molecular, and prognostic characteristics of glioma and its subtypes according to the current WHO classification.MethodsPatients who underwent surgery for glioma at Peking Union Medical College Hospital during 11 years were re-examined for tumor genetic alterations using next-generation sequencing, polymerase chain reaction-based assay, and fluorescence in situ hybridization methods and enrolled in the analysis.ResultsThe enrolled 452 gliomas were reclassified into adult-type diffuse glioma (ntotal=373; astrocytoma, n=78; oligodendroglioma, n=104; glioblastoma, n=191), pediatric-type diffuse glioma (ntotal=23; low-grade, n=8; high-grade, n=15), circumscribed astrocytic glioma (n=20), and glioneuronal and neuronal tumor (n=36). …”
    Get full text
    Article
  20. 20

    Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Syste... by Yin Yang, Jianyang Wang, Wenqing Wang, Tao Zhang, Jingjing Zhao, Yu Wang, Yexiong Li, Luhua Wang, Nan Bi

    Published 2022-01-01
    “…In arm-level surrogacy, very good correlations were also observed between 2-year (R2 = 0.823, 95% CI 0.814–0.832), 3-year (R2 = 0.843, 95% CI 0.833–0.850), 5-year (R2 = 0.852, 95% CI 0.843–0.859) PFS/TTP, and 5-year OS. …”
    Get full text
    Article